Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Relation Therapeutics has developed a proprietary AI-driven drug discovery platform that integrates high-resolution patient-derived data with advanced machine learning. Their initial pipeline focuses on osteoporosis with preclinical progress. In December 2024 they announced a major collaboration with GSK targeting fibrotic diseases and osteoarthritis. No clinical results have been published yet; the company remains preclinical but well-funded to advance toward the clinic.[5][8]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Relation Therapeutics.